Remove Controlling Remove Manufacturing Remove Pharmaceutical
article thumbnail

Where’s Your Visitor?

The Receptionist

In your manufacturing facility, you likely have areas—such as receiving, production, and shipping—that are off-limits for certain personnel and visitors. Depending on what you produce, you may also have clean rooms, climate-controlled areas, or storage for hazardous materials.

article thumbnail

A Simple Workaround to Overcome the Bureaucratic Mindset

Tanveer Naseer

Russell is an educational psychologist, author, executive coach and management consultant whose clients include Fortune 500 executives in aerospace, healthcare, pharmaceutical and biotechnology, information technology, telecommunications and oil and gas. The following is a guest post by Russell Bishop. So sue me” was the response.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

A kaleidoscope approach to leading: Five perspective shifts that can foster innovation

Work Life

In Tony’s work as a leadership coach, he worked with a pharmaceutical CEO who realized that her company’s long-term vision had become blurred. A manufacturing department head we worked with struggled with operational inefficiencies. We worked on refining her vision, focusing on sustainability and innovation.

article thumbnail

Critical Psychiatry Textbook, Chapter 16: Is There Any Future for Psychiatry? (Part Six)

Mad in America

Schatzberg has served as a consultant to or received honoraria from Abbott, Bristol-Myers Squibb, Corcept Therapeutics, Forest Laboratories, Janssen, Eli Lilly, Merck, Mitsubishi Pharmaceuticals, Organon, ParkeDavis, Pfizer, Pharmacia–Upjohn, Sanofi, Scirex, SmithKline Beecham, Solvay, and Wyeth–Ayerst. Make forced treatment unlawful.

article thumbnail

Consumer-Focused Approaches Won't Curb Health Care Spending

Inside Workplace Wellness

In the fourth quarter of last year, health care surpassed retail and manufacturing to become the largest source of jobs in the United States. Putting pressure in one area to control costs is like squeezing a balloon--it increases the cost somewhere else. of the patients who use it. Prescription Drug Spending in the U.S.

article thumbnail

The American Journal of Psychiatry’s Answer to MIA: A Silence that Speaks Volumes

Mad in America

However, in the summer of 1990, the Prozac story started to come undone, and it was then that the pharmaceutical industry, in concert with its thought leaders from academic psychiatry, plotted the strategy that has successfully cowed the mainstream media ever since. But he spoke to the public from the pulpit of Harvard Medical School.

Reporting 145
article thumbnail

It’s You, It’s Not Me: Treatment Resistant Depression and the Psychiatric Breakup

Mad in America

But we have two clues that influence such a choice: 1) What problem are they trying to solve and 2) How much control do they have over the situation? But the person prescribing them (or manufacturing them) has a different problem to solve: explaining why I should still trust them to guide me to wellness. billion worldwide.